Evidence map›Paper›PMID 34187592›Full record

ArticleImplementation science communications2021

Evaluation of carbapenem-resistant Enterobacteriaceae (CRE) guideline implementation in the Veterans Affairs Medical Centers using the consolidated framework for implementation research.

Cassie Cunningham Goedken, Marylou Guihan, Charnetta R Brown, Swetha Ramanathan, Amanda Vivo, Katie J Suda, Margaret A Fitzpatrick, Linda Poggensee, Eli N Perencevich, Michael Rubin and 3 more

Abstract read
In one paragraph

Article in Implementation science communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Cassie Cunningham GoedkenCenter for Access Delivery & Research and Evaluation (CADRE) Center, Iowa City VA Health Care System, 152, 601 Highway 6 West, Iowa City, IA, 52246, USA. cassie.goedken@va.gov.ORCID http://orcid.org/0000-0003-0990-1799
Marylou GuihanCenter of Innovation for Complex Chronic Healthcare (CINCCH), Edward Hines Jr. VA Hospital, Hines, IL, USA.
Charnetta R BrownEagle Hill Consulting, Arlington, VA, USA.
Swetha RamanathanCenter of Innovation for Complex Chronic Healthcare (CINCCH), Edward Hines Jr. VA Hospital, Hines, IL, USA.
Amanda VivoCenter of Innovation for Complex Chronic Healthcare (CINCCH), Edward Hines Jr. VA Hospital, Hines, IL, USA.
Katie J SudaCenter for Health Equity Research and Promotion (CHERP), VA Pittsburgh Health Care System, Pittsburgh, PA, USA.
Margaret A FitzpatrickCenter of Innovation for Complex Chronic Healthcare (CINCCH), Edward Hines Jr. VA Hospital, Hines, IL, USA.
Linda PoggenseeCenter of Innovation for Complex Chronic Healthcare (CINCCH), Edward Hines Jr. VA Hospital, Hines, IL, USA.
Eli N PerencevichCenter for Access Delivery & Research and Evaluation (CADRE) Center, Iowa City VA Health Care System, 152, 601 Highway 6 West, Iowa City, IA, 52246, USA.
Michael RubinDepartment of Veterans Affairs, VA Salt Lake City Healthcare System, Salt Lake City, UT, USA.
Heather Schacht ReisingerCenter for Access Delivery & Research and Evaluation (CADRE) Center, Iowa City VA Health Care System, 152, 601 Highway 6 West, Iowa City, IA, 52246, USA.
Martin EvansDepartment of Veterans Affairs, Lexington VA Medical Center, Lexington, KY, USA.
Charlesnika T EvansCenter of Innovation for Complex Chronic Healthcare (CINCCH), Edward Hines Jr. VA Hospital, Hines, IL, USA.

Funding

HSR&D Research Career Scientist AwardIK6HX003156 · VA · EDWARD HINES JR VA HOSPITAL · PI EVANS, CHARLESNIKA T · 2020 to 2025
–
Combating Antimicrobial Resistance through Rapid Implementation of Available Guidelines and Evidence (CARRIAGE)IP1HX001993 · VA · VA SALT LAKE CITY HEALTHCARE SYSTEM · PI EVANS, CHARLESNIKA T, PERENCEVICH, ELI N · 2020 to 2021
–
Funding support was provided by the Quality Enhancement Research Initiative (QUERI) Award QUE 15-269HSRD VA IK6 HX003156HSRD VA IP1 HX001993
6 · The paper itself

Abstract

backgroundInfections caused by carbapenem-resistant Enterobacteriaceae (CRE) and carbapenemase-producing (CP) CRE are difficult to treat, resulting in high mortality in healthcare settings every year. The Veterans Health Administration (VHA) disseminated guidelines in 2015 and an updated directive in 2017 for control of CRE focused on laboratory testing, prevention, and management. The Consolidated Framework for Implementation Research (CFIR) framework was used to analyze qualitative interview data to identify contextual factors and best practices influencing implementation of the 2015 guidelines/2017 directive in VA Medical Centers (VAMCs). The overall goals were to determine CFIR constructs to target to improve CRE guideline/directive implementation and understand how CFIR, as a multi-level conceptual model, can be used to inform guideline implementation.

methodsSemi-structured interviews were conducted at 29 VAMCs with staff involved in implementing CRE guidelines at their facility. Survey and VHA administrative data were used to identify geographically representative large and small VAMCs with varying levels of CRE incidence. Interviews addressed perceptions of guideline dissemination, laboratory testing, staff attitudes and training, patient education, and technology support. Participant responses were coded using a consensus-based mixed deductive-inductive approach guided by CFIR. A quantitative analysis comparing qualitative CFIR constructs and emergent codes to sites actively screening for CRE (vs. non-screening) and any (vs. no) CRE-positive cultures was conducted using Fisher's exact test.

resultsForty-three semi-structured interviews were conducted between October 2017 and August 2018 with laboratory staff (47%), Multi-Drug-Resistant Organism Program Coordinators (MPCs, 35%), infection preventionists (12%), and physicians (6%). Participants requested more standardized tools to promote effective communication (e.g., electronic screening). Participants also indicated that CRE-specific educational materials were needed for staff, patient, and family members. Quantitative analysis identified CRE screening or presence of CRE as being significantly associated with the following qualitative CFIR constructs: leadership engagement, relative priority, available resources, team communication, and access to knowledge and information.

conclusionsEffective CRE identification, prevention, and treatment require ongoing collaboration between clinical, microbiology, infection prevention, antimicrobial stewardship, and infectious diseases specialists. Our results emphasize the importance of leadership's role in promoting positive facility culture, including access to resources, improving communication, and facilitating successful implementation of the CRE guidelines.

Indexed as

Carbapenem-resistant Enterobacteriaceae (CRE)Consolidated Framework for Implementation Research (CFIR)Implementation scienceMulti-drug-resistant organisms (MDROs)

Identifiers

PMID34187592
PMCPMC8243642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.